A comparison of lipid and glycemic effects of pioglitazone and rosiglitazone in patients with type 2 diabetes and dyslipidemia: response to Goldberg et al.
| Autor: | Bell DSH, Goldberg RB, Kendall DM, Deeg MA, Buse JB, Zagar AJ, Pinaire JA, Tan MH, Khan MA, Perez AT, Jacober SJ, Bell, David S H |
|---|---|
| Zdroj: | Diabetes Care; Dec2005, Vol. 28 Issue 12, p2983-2986, 4p |
| Databáze: | Complementary Index |
| Externí odkaz: |
|